Ana Stella de Azevedo Silveira, Deyvis Macarof Loureiro Vasconcelos Rocha, Cecília Ribeiro de Faissol Attux, Claudiane Sales Daltio, Letícia Aparecida da Silva
Schizophrenia Program (PROESQ), Departament of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil.
Helio Elkis
Schizophrenia Program (PROJESQ), Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), São Paulo, SP, Brazil.
John Michael Kane
Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA.
Rodrigo Affonseca Bressan
Schizophrenia Program (PROESQ), Departament of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil.
Abstract:
Background: Despite of its global underuse, clozapine is still the golden standard antipsychotic for patients with treatment-resistant schizophrenia (TRS). Objective: To evaluate the patterns of clozapine and other antipsychotic drugs prescription in TRS in community mental health centers in São Paulo, Brazil. Methods: A multiple-choice questionnaire was applied to fifteen psychiatrists at five centers inquiring about patients’ clinical condition, adherence to oral treatment and current antipsychotic treatment. History of previous and current antipsychotic treatment was collected through medical chart review. Results: Out of 442 schizophrenia patients, 103 (23.3%) fulfilled the criteria for TRS. Fifty-eight patients (56.3%) were receiving polypharmacy; 30 (29.1%) were on atypical antipsychotic monotherapy, 14 (13.6%) were on typical antipsychotic monotherapy, 25 (24.3%) were taking depot antipsychotic medication and only 22 (21.4%) were receiving clozapine. Discussion: As well as in other parts of the world, many TRS patients (78.6%) receive other drugs instead of clozapine in São Paulo, the best evidence-based medication for patients with TRS. The government should make every effort to provide medical training and the equipment and logistic support to adequately serve those who could benefit from clozapine treatment at the community health centers
Keywords:Schizophrenia, drug resistance, drug prescriptions, clozapine, antipsychotic agents.